EUL-27527-30683
4 vaccinations
4 coded responses
44 check-ins
3 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 787 / TX
- Registered
- 2020-12-23
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-23
Registered in v-safe
-
2020-12-23
Dose 1 — Pfizer-BioNTech
- 2020-12-23
-
2020-12-27
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Fatigue or tirednessAdult check-in
-
2020-12-30
Health check-in — day 7, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2020-12-30
Report sent to call center — day 7, dose 1Be unable to do your normal daily activities1 call case(s)
- 2021-01-06
-
2021-01-13
Dose 2 — Pfizer-BioNTech
-
2021-01-13
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-13
Report sent to call center — day 0, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-14
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-14
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-15
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-01-15
Report sent to call center — days 1–6 daily, dose 2Be unable to do your normal daily activities1 call case(s)
-
2021-01-16
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-17
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2021-01-18
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tiredness, NauseaAdult check-in
-
2021-01-20
Health check-in — day 7, dose 2Feeling: Fair · Headache, Fatigue or tiredness, Abdominal painAdult check-in
- 2021-01-27
- 2021-02-03
- 2021-02-10
- 2021-02-17
- 2021-02-24
- 2021-04-14
- 2021-07-14
-
2021-10-01
Dose 3 — Pfizer-BioNTechCo-administered: Flu
-
2021-10-05
Survey response — days 1–6 daily, dose 3MedDRA: Erythema, Lymph node pain, Lymphadenopathy — Feeling: Poor · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Swollen, red, painful axillary lymph nodes on the side of the COVID shotMedDRA releases: 2024-11 · check-in free text available
-
2021-10-06
Survey response — days 1–6 daily, dose 3MedDRA: Lymphadenopathy — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesFree text: Lymph nodes still swollen but much less than beforeMedDRA releases: 2024-11 · check-in free text available
-
2021-10-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Headache, Fatigue or tirednessAdult check-in
- 2021-10-08
- 2021-10-15
- 2021-10-22
- 2021-10-29
- 2021-11-05
- 2021-11-12
- 2022-01-02
-
2022-04-01
Survey response — 6 months, dose 3MedDRA: Nasopharyngitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: I have a coldMedDRA releases: 2024-11 · check-in free text available
- 2022-10-01
-
2022-10-21
Dose 4 — Pfizer-BioNTech
- 2022-10-21
-
2022-10-22
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2022-10-23
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-10-24
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2022-10-26
- 2022-10-27
- 2022-10-28
- 2022-11-04
- 2022-11-11
- 2022-11-18
- 2022-11-25
- 2022-12-02
- 2023-01-20
-
2023-04-21
Survey response — 6 months, dose 4MedDRA: Urinary tract infection — Feeling: Good · Be unable to work or attend schoolMedDRA releases: 2024-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-23 | Pfizer-BioNTech | |
| 2 | 2021-01-13 | Pfizer-BioNTech | |
| 3 | 2021-10-01 | Pfizer-BioNTech | Flu |
| 4 | 2022-10-21 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 priority 2/3 (triaged and no follow up)
Free text
Release 10 — days 1–6 daily, dose 3
Systemic reaction (other): Swollen, red, painful axillary lymph nodes on the side of the COVID shot
Systemic reaction (other): Lymph nodes still swollen but much less than before
Release 11 — 6 months, dose 3
Symptoms: I have a cold
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Urinary tract infection | · | · | ✓ |
| SRO | Erythema | · | · | ✓ |
| SRO | Lymph node pain | · | · | ✓ |
| SRO | Lymphadenopathy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release